Dec 3, 2019
Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF), a Canadian biotechnology company and a leading developer in biosynthetically produced cannabidiol (“CBD”), this morning issued a release commenting on the recent news that the U.S. Drug Enforcement Agency (“DEA”) has removed Purisys, LLC’s CBD from Schedule I of the Controlled Substances Act (“CSA”). Purisys, the spin-out entity of Noramco, Inc.’s cannabinoids business, began operating as a stand-alone entity on October 1, 2019 and is expected to become independent from Noramco on January 1, 2020. Per the terms of a joint development agreement, Noramco is Willow’s exclusive manufacturing and distribution partner. Willow holds an informal partnership with Purisys through the agreement as well. “The descheduling of our partner Purisys’ CBD from the CSA signals a fundamental change in how the regulatory bodies in the United States view ultra-pure CBD,” Willow Biosciences president and CEO Trevor Peters stated in the news release. “At Willow, we have always maintained the view that as the market for CBD continues to unfold in the United States there will be an increased amount of oversight into the quality of the manufacturing process in addition to the specifications around the molecule itself. The partnership strives to produce ingredients that are of the highest quality and consistency. As we move towards commercialization of CBD, we believe a significant portion of the pharmaceutical and consumer products industries will desire the ultra-pure, consistent, and cost-effective ingredients that the partnership will be able to provide.”
To view the full press release, visit http://cnw.fm/2j1MN
About Willow Biosciences Inc.
Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.
NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://cnw.fm/WLLW
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
[email protected]
CBDWire is part of the InvestorBrandNetwork.
EXCLUSIVE: Amelia Dimoldenberg and Munya Chawawa’s manager is spearheading an Entertainment and New Media division at her international management outfit Three Six Zero. Rebecca Dowell is leading the division focused on multi-hyphenate talent, digital creators and IP-led projects, and will continue working with these high-profile creators, along with new clients like feminist arts and culture […]
The Bridget Jones Prize will go to the author of the funniest 1,000-word diary-style piece of writing.
The Grammy-nominated artist was due to start a run of shows for his latest album Bulldozer!! next month.
At this year’s Marché du Film at the Cannes film festival, it would be no exaggeration to say that Japanese content and creators were everywhere you turned. Designated ‘Country of Honour’ at the market, Japan was involved in a slew of panels, workshops and labs; played a prominent role in Cannes flagship programs, including Cannes […]
It’s an exciting time for Japanese cinema, with franchise hits from Demon Slayer to Godzilla stomping around the world, and Japanese arthouse titles taking the spotlight at major film festivals including Venice, Toronto and Cannes. This year’s Tokyo International Film Festival, taking place in the Hibiya-Ginza district of the city from October 26 to November […]
This movie spooooooked me as a kid! View Entire Post ›
Noel Clarke has pleaded not guilty to six sexual offense charges. Appearing at Westminster Magistrates Court in London on Wednesday morning, the actor, writer and director entered not guilty pleas in relation to all the charges, which include two charges of sexual assault, three charges of voyeurism and one charge of exposure. The charges relate […]
The Other Bennet Sister producer Jane Tranter has launched an impassioned plea for TV makers to search out stories that “that will make our world a more empathetic place.” In a keynote talk at MIA Market this week, the Bad Wolf Production CEO and co-founder used the example of a “farmer in his 70s” who […]
EXCLUSIVE: John Leguizamo, star of Christopher Nolan’s The Odyssey, is to be honored at the upcoming São Paulo International Film Festival, Brazil. The program of the 50th edition of the festival, which runs through October 29, will include a masterclass with the actor, as well as the presentation of the Leon Cakoff Award, named after […]
Ozzy Osbourne’s final “Back to the Beginning” concert kept him “flying high” until the day he died, his wife Sharon Osbourne said. Speaking at a London screening of the film “Ozzy & Black Sabbath: Back to the Beginning” — which chronicles the July 5, 2025 Birmingham show that took place just weeks before the heavy […]
“I was a kid — how would you respond, even now?!” View Entire Post ›
Thailand’s and Nepal’s Oscar submissions, “9 Temples to Heaven” and “Elephants in the Fog,” are among 10 titles competing at the 27th edition of Tokyo Filmex, which will run Nov. 20–29 in the Japanese capital’s Yurakucho district. Taiwanese actor Lee Kang-sheng, who has appeared in every feature by auteur Tsai Ming-liang since “Rebels of the […]
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.